Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formulation to treat...
Daiichi Sankyo Company, Limited announced that it has initiated in Japan a first-in-human phase 1...
Humanigen Reports Positive Phase 3 Topline Results Improves Survival Without Need for Mechanical Ventilation...
Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called...
Foresee Pharma Announces Dosing of First Patient in Phase 2/3 Clinical Trial of FP-025...
Foresee Pharmaceuticals Co., Ltd. announced the initiation of patient dosing in the Phase 2/3 clinical...
Lilly, Vir And GSK Report Positive Topline Data From COVID-19 Trial Of Bamlanivimab With...
Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced topline data from the...
CyanVac Selects Exothera for the Development and GMP Mfg anufacturing of its COVID-19 Intranasal...
CyanVac LLC, a vaccine company, announced that they have selected Exothera S.A., a full-service Contract...
Phase 3 Trial Shows REGEN-COV antibody Cocktail Reduced Hospitalization or Death by 70% in...
Regeneron Pharmaceuticals, Inc. announced positive topline results from the largest trial to date assessing a...
BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging
BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe...
Accenture and Phesi urges pharmaceutical companies to make use of synthetic data in clinical...
Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, and Accenture,...
CureVac Expands CVnCoV COVID-19 Vaccine Candidate Clinical Trial Analyses to Include Phase 2b/3 Variant...
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on...
Moderna starts Phase I study of new Covid-19 vaccine candidate
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the...
